TP53 and neoplasm: These properties may be attained through the sequential acquisition of genetic mutations in proto-oncogenes (e.g., KRAS) and tumor-suppressor genes (e.g., TP53) that promote cancer initiation, progression, and maintenance (Hanahan & Weinberg, 2011; Vogelstein et al, 2013; Bailey et al, 2018).